Buy CVRX by Dec 23, 2026.

If you want to know why institutional giants like Johnson & Johnson are backing $CVRX, just look at the bulletproof clinical data the company just dropped. Here is a quick breakdown of their latest case study chart and what it actually means for the long-term investment thesis: **1. Device Over Drugs is REAL 📉** The chart highlights a severe heart failure (HFrEF) patient. Before the Barostim implant, their pulmonary artery pressure (PA) was dangerously high (\~45-50 mmHg), even with heavy …